Rona Ortenberg Selected Research

Melanoma (Melanoma, Malignant)

6/2021	microRNA expression patterns in tumor infiltrating lymphocytes are strongly associated with response to adoptive cell transfer therapy.
1/2021	Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients.
1/2020	Immune co-culture cell microarray - a feasible tool for high-throughput functional investigation of lymphocyte-cancer interactions.
1/2019	Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial Dependence.
1/2018	Regulation of CEACAM1 Protein Expression by the Transcription Factor ETS-1 in BRAF-Mutant Human Metastatic Melanoma Cells.
5/2016	SOX9 indirectly regulates CEACAM1 expression and immune resistance in melanoma cells.
3/2015	A longitudinal study of CEACAM1 expression in melanoma disease progression.
5/2014	CEACAM1 promotes melanoma cell growth through Sox-2.
6/2013	MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth.
1/2013	Development of allogeneic NK cell adoptive transfer therapy in metastatic melanoma patients: in vitro preclinical optimization studies.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rona Ortenberg Research Topics

Disease

18	Melanoma (Melanoma, Malignant) 06/2021 - 01/2009
12	Neoplasms (Cancer) 01/2021 - 01/2009
2	Neoplasm Metastasis (Metastasis) 03/2015 - 12/2011
1	Disease Progression 03/2015
1	Nevus (Nevi) 05/2014
1	Uveal melanoma 12/2011
1	Pathologic Processes 04/2011

Drug/Important Bio-Agent (IBA)

7	CEACAM1 ProteinIBA 01/2018 - 02/2010
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 12/2011
3	MicroRNAs (MicroRNA)IBA 06/2021 - 04/2011
3	Cell Adhesion Molecule-1IBA 05/2016 - 12/2011
3	Carcinoembryonic AntigenIBA 05/2016 - 12/2011
2	Glycoproteins (Glycoprotein)IBA 05/2016 - 06/2012
2	AntibodiesIBA 01/2013 - 01/2009
1	ParaffinIBA 01/2020
1	Formaldehyde (Formol)FDA Link 01/2020
1	ProteomeIBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2018
1	Proto-Oncogene Protein c-ets-1IBA 01/2018
1	SOX9 Transcription FactorIBA 05/2016
1	EnzymesIBA 06/2013
1	RNA (Ribonucleic Acid)IBA 06/2013
1	Adenosine DeaminaseIBA 06/2013
1	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2013
1	HLA-C Antigens (HLA-C)IBA 01/2013
1	ChemokinesIBA 10/2012
1	Chemokine ReceptorsIBA 10/2012
1	AntigensIBA 06/2012
1	Monoclonal AntibodiesIBA 06/2012
1	IpilimumabIBA 01/2012
1	Cell Adhesion MoleculesIBA 12/2011
1	LigandsIBA 01/2009

Therapy/Procedure

6	Therapeutics 06/2021 - 06/2012
5	Immunotherapy 01/2021 - 01/2012
1	Fecal Microbiota Transplantation 01/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2013
1	Stem Cell Transplantation 01/2009